How should I prepare and administer N-acetylcysteine 600 mg intravenously twice daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Mix N-Acetylcysteine 600 mg IV BID

N-acetylcysteine must be diluted in sterile water for injection, 0.45% sodium chloride (half-normal saline), or 5% dextrose in water prior to intravenous administration because the undiluted solution is hyperosmolar (2600 mOsmol/L). 1

Preparation Steps

Dilution Requirements

For a 600 mg dose, you need to dilute the concentrated NAC solution to achieve a safe osmolarity for IV administration:

  • Source concentration: NAC is supplied as 20% w/v solution (200 mg/mL) 1
  • Volume needed: 3 mL of 20% NAC solution contains 600 mg
  • Dilution options: Mix with sterile water for injection, 0.45% sodium chloride, or D5W 1

Recommended Dilution Protocol

Dilute 3 mL of 20% NAC (600 mg) in 100-250 mL of compatible diluent to achieve a final concentration between approximately 2.4-6 mg/mL, which provides physiologically safe osmolarity (generally not less than 150 mOsmol/L). 1

The osmolarity varies by diluent choice:

  • Sterile water: Lowest osmolarity (may need adjustment in pediatrics to ≥150 mOsmol/L)
  • Half-normal saline: Intermediate osmolarity
  • D5W: Highest osmolarity 1

Preparation Instructions

  1. Visually inspect the NAC vial for particulate matter and discoloration before use
  2. Withdraw 3 mL of 20% NAC solution (600 mg) using aseptic technique
  3. Add to 100-250 mL of your chosen diluent (sterile water, 0.45% NaCl, or D5W)
  4. Mix gently - the solution color ranges from colorless to slight pink or purple (this color change does not affect quality) 1
  5. Label appropriately with patient information, dose, and preparation time

Administration

  • Infusion time: Administer over 1-4 hours (not as a rapid bolus)
  • Frequency: Twice daily (BID) as prescribed
  • Filter: The inhalational preparation can be filtered through a 22-micron filter if using that formulation 2

Storage and Stability

  • Room temperature stability: The diluted solution can be stored for 24 hours at room temperature 1
  • Extended stability data: Studies show stability up to 60 hours when properly prepared, though FDA labeling recommends 24-hour maximum 2
  • Discard unused portion - if a vial was previously opened, do not use for IV administration 1

Critical Safety Considerations

Hypersensitivity reactions occur in 8-10% of patients, most commonly during the initial dose. Monitor for:

  • Urticaria/facial flushing (most common)
  • Pruritus
  • Respiratory symptoms (bronchospasm, wheezing)
  • Hypotension (rare but serious) 1

Slow the infusion rate if reactions occur - most are rate-related and resolve with temporary discontinuation and antihistamine administration. 3

Do not use undiluted NAC intravenously - the hyperosmolar solution can cause severe adverse reactions. 1

Context-Specific Notes

This 600 mg BID dosing differs from the standard acetaminophen overdose protocol (which uses weight-based dosing with loading and maintenance phases). The 600 mg BID regimen may be used for:

  • Non-acetaminophen indications (contrast nephropathy prevention, mucolytic therapy)
  • Maintenance therapy after completion of standard overdose protocol
  • Off-label applications 4, 5, 6

For acetaminophen overdose specifically, follow the FDA-approved three-bag protocol: 150 mg/kg loading dose, then 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours. 1, 3

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.